News - DelveInsight Business Research

Interpreting the Growth and Major Developments in the Medical Device Contract Manufacturing Market

medical-device-contract-manufacturing

Contract manufacturing is a type of outsourcing in which a company manufactures entire products or parts of larger products. Such services are employed in the medical device sector as well. Medical device OEMs (original equipment manufacturers) are companies that own the product outsource manufacturing to another medical device contract manufacturing companies that specialize in a specific area,… Continue reading Interpreting the Growth and Major Developments in the Medical Device Contract Manufacturing Market

Check-Cap’s Pivotal Trial for C-Scan; Curebase and Flow Neuroscience’s tDCS Device; Brainlab Acquires Majority Share in medPhoton; GE Healthcare to Invest in Pulsenmore; Medtronic’s Drug-Eluting Coronary Stent System; Remedee’ Endorphin Stimulation Solution;

MedTech News and Insights for Check-Cap, Curebase, Brainlab, and GE

Check-Cap Initiated the US Pivotal Trial for C-Scan® On May 11, 2022, Check-Cap Ltd., a clinical-stage diagnostic company initiated the US pivotal trial for C-Scan® at Mayo Clinic in Rochester Minnesota. C-Scan is the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC). The company has… Continue reading Check-Cap’s Pivotal Trial for C-Scan; Curebase and Flow Neuroscience’s tDCS Device; Brainlab Acquires Majority Share in medPhoton; GE Healthcare to Invest in Pulsenmore; Medtronic’s Drug-Eluting Coronary Stent System; Remedee’ Endorphin Stimulation Solution;

Evaluating the Major Developments in the Smart Pills Market

Smart Pill - Benefits, Challenges, Applications, Key Companies, Future Growth

As our medical demands rise, so does the technology that distributes our medications. With innovative phone apps, alarms, smart packaging, and smart pills, there is no excuse to miss a dosage or forget to take your medication. With the evolution of wireless devices and microscopic cameras, the terms “embeddable” and “wearables” are becoming more widespread,… Continue reading Evaluating the Major Developments in the Smart Pills Market

BMS Sells NY Biologics Plant; FDA Approves Mitsubishi Tanabe’s Radicava, Love Pharma Acquires MicroDoz; Sandoz Launches Generic of Roche’s Esbriet; Pfizer to Acquire Biohaven Pharma; eureKARE’s Cell and Gene Therapy CDMO; Atamyo’s LGMD Gene Therapies; FDA approves Eli Lilly’s Type 2 Diabetes Treatment

Pharma News and Analysis for BMS, Sandoz, and Pfizer

Love Pharma Completes the Acquisition of MicroDoz Therapy LOVE Pharma Co. has announced the completion of its acquisition of MicroDoz Theraphy Inc. (“MicroDoz”). Love Pharma holds exclusive manufacturing, marketing, packaging, selling, and distribution licenses in Europe, the United Kingdom, and North America. Under the terms of the share exchange agreement (the “Share Exchange Agreement”) entered… Continue reading BMS Sells NY Biologics Plant; FDA Approves Mitsubishi Tanabe’s Radicava, Love Pharma Acquires MicroDoz; Sandoz Launches Generic of Roche’s Esbriet; Pfizer to Acquire Biohaven Pharma; eureKARE’s Cell and Gene Therapy CDMO; Atamyo’s LGMD Gene Therapies; FDA approves Eli Lilly’s Type 2 Diabetes Treatment

Discovering the Latest Developments in the Rapidly Advancing Abdominal Aortic Aneurysm Treatment Landscape

The heart is the most important muscle in the body. The aorta is the largest artery in the body and is the blood vessel that carries oxygen-rich blood away from the heart to all body parts. The section of the aorta that runs through the chest is called the thoracic aorta, and as the aorta… Continue reading Discovering the Latest Developments in the Rapidly Advancing Abdominal Aortic Aneurysm Treatment Landscape

Assessing How Emerging Therapies Will Transform the AL Amyloidosis Treatment Dynamics

AL Amyloidosis Therapeutics Market Outlook

AL Amyloidosis is a rare disease, with around 8,500 new cases diagnosed each year in the 7MM. This disease mostly affects elderly persons median age of 64, with slight male predominance (54%). As per our estimates, the highest AL Amyloidosis incidence was observed in the US in 2021. Moreover, there are more than 30 different… Continue reading Assessing How Emerging Therapies Will Transform the AL Amyloidosis Treatment Dynamics

Abbott’s Alinity m STI Assay; Phillips’ MR 7700 System; HOYA’s MiYOSMART Spectacle Lens; Magneto’s Pulmonary Embolism Treatment; Owen Mumford and Stevanto Group’s Collaboration Deal; Elekta’s Radiosurgery System-Elekta Esprit

Latest MedTech News and Updates for Abbott, Philips and HOYA

Abbott Receives Regulatory Approval from US FDA for Alinity™ m STI Assay On May 04, 2022, the US Food and Drug Administration (FDA) granted the regulatory approval to Alinity™ m STI Assay developed by Abbott which is capable of simultaneously detecting and differentiating four common sexually transmitted infections (STIs).  It is a first-of-its-kind multiplex test… Continue reading Abbott’s Alinity m STI Assay; Phillips’ MR 7700 System; HOYA’s MiYOSMART Spectacle Lens; Magneto’s Pulmonary Embolism Treatment; Owen Mumford and Stevanto Group’s Collaboration Deal; Elekta’s Radiosurgery System-Elekta Esprit

Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases

Mobile Apps for Chronic Diseases Management

Over the past few years, the prevalence of the chronic disease has grown significantly. The rising prevalence is leading to a severe social and economical burden on the individuals and their families. Chronic diseases are long-lasting conditions with endless side effects associated with them. Despite the rise in morbidity and mortality, the global response to… Continue reading Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases

AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA

Pharma News and Update for Incyte and Aptose

AstraZeneca’s Farxiga Meets Primary Endpoints in Phase 3 Heart Failure Trial Farxiga, an SGLT2 inhibitor from AstraZeneca, has shown positive results in a phase 3 Heart Failure trial, putting it back in contention with Jardiance from Boehringer Ingelheim and Eli Lilly. The DELIVER trial’s top-line results demonstrated that Farxiga (dapagliflozin) was able to lower the… Continue reading AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA

Most Promising Therapies in the Food Allergy Treatment Market

food-allergy-treatment-landscape

Food allergies are becoming a global concern. According to the World Allergy Organization, “food allergy impacted around 2.5% of the general population, but prevalence figures ranged from 1% to 10%.” The increasing incidence of food allergies is raising food safety and public health issues and it is estimated that 4%-6% of children and 4% of… Continue reading Most Promising Therapies in the Food Allergy Treatment Market